Management of ITP

Moffitt Cancer Center's 17th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies
Avatar

Managing Hematologic Toxicities From Immunotherapeutic Agents

By Moffitt Cancer Center's 17th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies FEATURING Michael Jaglal
By Moffitt Cancer Center's 17th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies FEATURING Michael Jaglal
289 views
February 14, 2022
0 Comments
Login to view comments. Click here to Login
06:24
Weill Cornell Medicine Oncology & Hematology

SYK Inhibitors for the Treatment of ITP

Feat. J. Bussel
17:31
Aron Kefela

Fostamatinib in the Treatment of Chronic ITP

15:32
Amy Zhou

Second Line Therapy for ITP

14:24
Cindy Neunert

Venous Thromboembolism and Immune Thrombocytopenia

33:05
University of Colorado Division of Hematology

UC Denver ASH Review: Updates on Benign Hematology

Feat. A. Metjian
14:00
Cleveland Clinic's 2022 Management of Checkpoint Inhibitor-Related Toxicities

Hematologic irAEs (VTEs)

Feat. K. McCrae
19:13
Yale Cancer Center

ASH 2021 Highlights on Thrombosis and Anticoagulation

Feat. A. Pine
41:39
19th Annual International Ultmann Chicago Lymphoma Symposium

Venous Thromboembolism in Lymphoma: Risk Stratification, Prophylaxis…

Feat. K. Cohen
21:51
Rush University Medical Center

Thrombotic Microangiopathies: Modern Diagnosis and Treatments

Feat. S. Cataland
31:21
Indy Hematology Review

Benign Hematology: Clotting, Bleeding, and More

Feat. C. Kessler